List of Studies ( Metabolite:ETrE(11Z,14Z,17Z))
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004203 | AN006989 | RPR2 NE nonNE comparison | Tumor cells | Mouse | Cancer | Stanford University | LC-MS |
| ST004138 | AN006860 | Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus | Feces | Human | Autoimmune disease | Hangzhou Xixi Hospital | LC-MS |
| ST004138 | AN006860 | Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus | Feces | Human | Liver disease | Hangzhou Xixi Hospital | LC-MS |
| ST003745 | AN006150 | Screen potential marker proteins influencing spermatogenesis in the testes of Shandong Black Cattle bulls via multi-omics integrated analysis. | Testes | Cattle | Qingdao Agricultural University | LC-MS | |
| ST003327 | AN005450 | Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial Metabolomics | Blood | Human | Trauma | University of Colorado Anschutz Medical Campus | LC-MS |
| ST002576 | AN005611 | Role of environmental toxicants in obesity-related cardiovascular disease: Plasma untargeted LC-HRMS analysis (part 1 of 3) | Blood | Human | Heart disease | Boston University | LC-MS |
| ST002309 | AN003772 | Targeting malaria parasites with novel derivatives of azithromycin | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002281 | AN003725 | Metabolite patterns between isogenic normal hiPSCs and Trisomy hiPSC | iPSC cells | Human | Down syndrome | Guangdong Provincial People's Hospital | APCI-MS |
| ST002063 | AN003362 | Intravenous lipopolysaccharide infusion and the bovine metabolome | Blood | Cow | Hyperlipidemia | Cornell University | LC-MS |
| ST001315 | AN002190 | Retargeting azithromycin-like compounds as antimalarials with dual modality | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001275 | AN002116 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001175 | AN001951 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001098 | AN001786 | Metabolomics of Metabolic Risk in Patients Taking Atypical Antipsychotics (part II) | Blood | Human | Schizophrenia | University of Michigan | GC-MS |
| ST000917 | AN001497 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | Urine | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000916 | AN001491 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Blood | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000915 | AN001485 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000546 | AN000833 | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000539 | AN000819 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash University | LC-MS | |
| ST000414 | AN000656 | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST000403 | AN000643 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences | LC-MS | |
| ST000233 | AN000350 | Metabolomics Reveals that Aryl Hydrocarbon Receptor Activation by Environmental Chemicals Induces Systemic Metabolic Dysfunction in Mice (Part II) | Unspecified | Mouse | Pennsylvania State University | GC-MS |
